Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group
William Shomali(Stanford Medicine), Jason Gotlib(Stanford University), Andreas Reiter(Heidelberg University), Jay Patel(University of Utah), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Philomena Colucci(Incyte (United States)), Jean‐Jacques Kiladjian(Délégation Paris 5), Cheryl Langford(Stanford University), Tracy I. George(University of Utah)
Cited by 14
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k